These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17559753)

  • 1. Single- and multiple-dose bioequivalence of two once-daily tramadol formulations using stereospecific analysis of tramadol and its demethylated (M1 and M5) metabolites.
    Eradiri O; Sista S; Lai JC; Nguyen OH; Silverstone PH
    Curr Med Res Opin; 2007 Jul; 23(7):1593-604. PubMed ID: 17559753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative bioequivalence studies of tramadol hydrochloride sustained-release 200 mg tablets.
    Khandave SS; Sawant SV; Joshi SS; Bansal YK; Kadam SS
    Drug Des Devel Ther; 2010 Nov; 4():367-74. PubMed ID: 21151623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence evaluation of single doses of two tramadol formulations: a randomized, open-label, two-period crossover study in healthy Brazilian volunteers.
    Silva Mde F; Schramm SG; Kano EK; Mori Koono EE; Porta V; dos Reis Serra CH
    Clin Ther; 2010 Apr; 32(4):758-65. PubMed ID: 20435245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative bioavailability between two Tramadol once-daily oral formulations.
    Hernandez-Lopez C; Martinez-Farnos L; Karhu D; Perez-Campos T; Rovira S; Encina G
    Methods Find Exp Clin Pharmacol; 2006; 28(6):373-8. PubMed ID: 16894407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers.
    Pedersen RS; Damkier P; Brøsen K
    Eur J Clin Pharmacol; 2006 Jul; 62(7):513-21. PubMed ID: 16763825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of enantiomers of trans-tramadol and its active metabolite, trans-O-demethyltramadol, in human subjects.
    Liu HC; Liu TJ; Yang YY; Hou YN
    Acta Pharmacol Sin; 2001 Jan; 22(1):91-6. PubMed ID: 11730570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative bioavailability of two once-daily tramadol HCl 200 mg extended-release products in healthy volunteers.
    Groenewoud G; Cronje T; Potgieter MA; Karhu D
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):146-57. PubMed ID: 20137767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic evaluation of a new oral sustained release dosage form of tramadol.
    Malonne H; Sonet B; Streel B; Lebrun S; De Niet S; Sereno A; Vanderbist F
    Br J Clin Pharmacol; 2004 Mar; 57(3):270-8. PubMed ID: 14998423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and bioequivalence of single dose and multiple doses of immediate- and extended-release formulations of dexibuprofen in healthy Chinese subjects.
    Xu MJ; Zou C; H Chu J; Wu T; Liu SJ; Zhang J; Chen M; Liu F; Xiong NN; Ju WZ; S Tan H
    Int J Clin Pharmacol Ther; 2011 Mar; 49(3):237-46. PubMed ID: 21329626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Route-dependent stereoselective pharmacokinetics of tramadol and its active O-demethylated metabolite in rats.
    Parasrampuria R; Vuppugalla R; Elliott K; Mehvar R
    Chirality; 2007 Mar; 19(3):190-6. PubMed ID: 17192836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereospecific high-performance liquid chromatographic analysis of tramadol and its O-demethylated (M1) and N,O-demethylated (M5) metabolites in human plasma.
    Mehvar R; Elliott K; Parasrampuria R; Eradiri O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):152-9. PubMed ID: 17257910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of the biopharmaceutical properties of tramadol sustained-release formulations for chrono-pharmacologically optimized treatment of pain from various sources.
    Warnke A; Schug B; Vanderbist F; Erbist ; Blume H
    Int J Clin Pharmacol Ther; 2009 Jun; 47(6):405-12. PubMed ID: 19473603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype.
    García-Quetglas E; Azanza JR; Sádaba B; Muñoz MJ; Gil I; Campanero MA
    Pharmacol Res; 2007 Feb; 55(2):122-30. PubMed ID: 17175164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of extended-release versus conventional tramadol/acetaminophen fixed-dose combination tablets: an open-label, 2-treatment, multiple-dose, randomized-sequence crossover study in healthy korean male volunteers.
    Yi S; Chung YJ; Kim TE; Shin HS; Yoon SH; Cho JY; Jang IJ; Shin SG; Yu KS
    Clin Ther; 2011 Jun; 33(6):728-37. PubMed ID: 21704237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose pharmacokinetics of co-crystal of tramadol-celecoxib: Results of a four-way randomized open-label phase I clinical trial in healthy subjects.
    Videla S; Lahjou M; Vaqué A; Sust M; Encabo M; Soler L; Sans A; Sicard E; Gascón N; Encina G; Plata-Salamán C
    Br J Clin Pharmacol; 2017 Dec; 83(12):2718-2728. PubMed ID: 28810061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of multiple doses of co-crystal of tramadol-celecoxib: findings from a four-way randomized open-label phase I clinical trial.
    Videla S; Lahjou M; Vaqué A; Sust M; Escriche M; Soler L; Sans A; Sicard E; Gascón N; Encina G; Plata-Salamán C
    Br J Clin Pharmacol; 2018 Jan; 84(1):64-78. PubMed ID: 28888220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective pharmacokinetic analysis of tramadol and its main phase I metabolites in healthy subjects after intravenous and oral administration of racemic tramadol.
    García Quetglas E; Azanza JR; Cardenas E; Sádaba B; Campanero MA
    Biopharm Drug Dispos; 2007 Jan; 28(1):19-33. PubMed ID: 17061296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacokinetics of a once-daily tramadol extended-release tablet and an immediate-release reference product following single-dose and multiple-dose administration.
    Karhu D; Fradette C; Potgieter MA; Ferreira MM; Terblanché J
    J Clin Pharmacol; 2010 May; 50(5):544-53. PubMed ID: 20051587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of the pharmacokinetics of a sustained-release formulation of a tramadol/acetaminophen combination in healthy subjects.
    Im YJ; Jeon JY; Kim EY; Kim Y; Oh DJ; Yoo JS; Shin DH; Chae SW; Kim MG
    Clin Ther; 2015 Feb; 37(2):376-89. PubMed ID: 25618318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioequivalence study of tramadol by intramuscular administration in healthy volunteers.
    Chao CK; Yu LL; Su LL; Liu CM; Yang TH; Chen CM
    Arzneimittelforschung; 2000 Jul; 50(7):636-40. PubMed ID: 10965421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.